Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Our purpose in this study is to explore the feasibility of treatment of non promyelocytic
Acute myeloid leukaemia on elderly patients. We select ten patients with age further than 60
with comorbidity and treat by low dose cytosar subcutaneous plus arsenic trioxide for ten
days in month. We will assess overall response rate and overall survival in end of one year.